Skip to main content

Table 3 List of the miRNAs used to classify patients into R and NR groups

From: Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C

Gene name fold change (R/NR) T-test   Selection by MCCV
    Rank appearance frequency in this classification (%) appearance number of times
hsa-miR-122a 1.50 6.70E-02 1 98.57 690
hsa-miR-21 1.13 5.43E-01 2 89.86 629
hsa-let-7a 1.15 4.23E-01 3 88.71 621
hsa-let-7f 1.24 3.01E-01 4 87.43 612
hsa-miR-148a 1.70 4.51E-02 5 82.71 579
hsa-miR-192 1.24 1.93E-01 6 81.71 572
hsa-miR-126 1.21 3.19E-01 7 74.14 519
hsa-miR-22 1.04 7.88E-01 8 68.43 479
hsa-miR-194 1.20 3.63E-01 9 64.29 450
hsa-miR-23b 1.30 2.06E-01 10 62.00 434
hsa-miR-125b 1.23 2.88E-01 11 61.86 433
hsa-miR-494 0.45 8.17E-02 12 61.14 428
hsa-miR-19b 1.17 3.86E-01 13 61.14 428
hsa-miR-29a 1.11 5.44E-01 14 59.86 419
hsa-miR-26a 1.13 5.38E-01 15 58.43 409
hsa-let-7b 1.01 9.37E-01 16 56.86 398
hsa-miR-142-3p 1.15 5.54E-01 17 52.71 369
hsa-miR-215 1.28 3.93E-01 18 52.00 364
hsa-miR-101 1.31 1.26E-01 19 49.00 343
hsa-miR-451 1.35 5.25E-01 20 48.14 337
hsa-miR-145 0.99 9.76E-01 21 47.14 330
hsa-let-7g 1.15 4.84E-01 22 44.00 308
hsa-miR-29c 1.23 2.94E-01 23 43.71 306
hsa-miR-26b 1.37 2.85E-01 24 43.14 302
hsa-miR-768-3p 1.00 9.91E-01 25 36.29 254
hsa-let-7c 1.16 3.76E-01 26 36.14 253
hsa-miR-370 0.43 7.36E-02 27 35.57 249
hsa-miR-92 1.07 6.65E-01 28 34.14 239
hsa-miR-16 1.11 6.18E-01 29 26.71 187
hsa-miR-29b 1.14 5.19E-01 30 25.71 180
hsa-miR-27b 1.40 1.15E-01 31 25.71 180
hsa-miR-24 1.08 6.56E-01 32 20.57 144
hsa-miR-107 1.00 9.81E-01 33 19.57 137
hsa-miR-143 0.95 7.99E-01 34 18.43 129
hsa-miR-214 0.85 3.61E-01 35 17.86 125